Cholesterol is a neutral lipid that plays a crucial role in maintaining the integrity of biological membranes and serves as a precursor for the synthesis of many endocrine mediators. Conjugation of cholesterol moiety to active compounds for disease therapy or diagnosis is an attractive approach. BOC Sciences offers custom synthesis services for cholesterol conjugations.Our experts use standard chemical synthesis methods to conjugate cholesterol molecules to peptide, oligonucleotides, siRNA, polymers and antibody to improve their pharmacokinetic behavior, cellular uptake, target specificity and safety.
Fig 1. Cholesterol-Polymers Conjugation. (Rasmussen, K. F.; et al. 2014)
Fig 2. Lipid-porphyrin conjugate and cholesterol combination. (Massiot, J.; et al. 2022)
Conjugation of peptide lead compounds to cholesterol can facilitate the binding of peptide drugs to plasma proteins, thereby improving pharmacokinetics. Our peptide experts provide novel strategies for the synthesis of cholesterol-peptide conjugates that could be used for gene delivery and antiviral drug development.
Modification of oligonucleotides through conjugation is an effective way to promote their therapeutic applications and expand their development. Cholesterol conjugation of oligonucleotides is a widely used lipid conjugation method which greatly improves the biodistribution of conjugated oligonucleotides. BOC Sciences offers reliable services of cholesterol conjugation of oligonucleotides to achieve the optimized ligand-specific oligonucleotide uptake by selecting the best structural design strategy.
In the past two decades, siRNA has shown promising potential as a therapeutic agent. However, the drawback of siRNA is its low efficiency of delivery to target cells, which limits the application of siRNA drugs. One of the most powerful strategies for delivering siRNA to target cells is to covalently link siRNA to biomolecules. Combined with our expertise in modified nucleic acid synthesis, BOC Sciences can synthesize high quality cholesterol-siRNA conjugates that can be employed as a versatile siRNA delivery platform.
Photodynamic therapy is a promising approach to fight bacterial infections because it induces few side effects, does not generate resistance, and enables precise treatment. However, most photosensitizers (PSs) have disadvantages such as poor water solubility, severe self-quenching and potential toxicity. BOC Sciences provides custom service of synthesis of cholesterol-conjugated polymer-based photosensitizer. Our teams use cholesterol to conjugate to PSs by performing carboxyamine reaction or acylchloramine reaction with the application of cationic polymers.
At BOC Sciences, our experts can synthesize cholesterol-conjugated poly(D,L-Lactide) (PLA)-based polymer micelles with larger hydrodynamic diameters and lower critical micelle concentrations (CMC), which can be used as a suitable delivery system for poorly soluble chemotherapeutic drugs in cancer therapy.
Cholesterol-antibody conjugate has become a general strategy to increase the potency of antiviral antibodies. The cholesterol-conjugated antibody shows increased antiviral potency through binding to lipid raft domains on the cellular membranes. Our experts offer a variety of cholesterol-conjugated antibodies by performing cholesterol conjugation at several positions, including variable and constant domains.